Immunohistochemistry Market to Grow at a CAGR of 7.4% to reach US$ 3,585.31 million from 2021 to 2028

    Immunohistochemistry Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Application (Diagnostics, and Drug Testing); Product (Antibodies, Equipment, Reagents, and Kits); End User (Hospitals and Diagnostic Laboratories, Research Institutes, and Others), and Geography.

    Publication Month: Sep 2019 | Report Code: TIPRE00006184 | No. of Pages: 259 | Category: Biotechnology | Status: Published

    The immunohistochemistry market is projected to reach US$ 3,585.31 million by 2028 from US$ 2,171.61 million in 2021; it is estimated to register a CAGR of 7.4% from 2021 to 2028.

    Immunohistochemistry (IHC) uses microscopy-based techniques to observe cellular components such as proteins or other macromolecules in a tissue sample. It is a routinely used tool in health care and pathology. IHC is widely used in research applications where molecules of interest are analyzed to study their roles in both healthy and diseased cells and tissues on the cellular, molecular, or tissue level. Numerous IHC methods can be used to localize antigens. Parameters like specimen types and assay sensitivity are majorly considered in IHC.

    The immunohistochemistry market is segmented into product, application, end user, and geography. By geography, the market is broadly segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South and Central America. The report offers insights and in-depth analysis of the market, emphasizing parameters such as market trends, technological advancements, and market dynamics, along with the analysis of the competitive landscape of the globally leading market players.

    Lucrative Regions for Immunohistochemistry Market

    Lucrative Regions for Immunohistochemistry Market

    Get more information on this report :



    Market Insights

    Rising Incidence of Chronic and Infectious Diseases Drive Immunohistochemistry Market Growth

    Immunohistochemistry (IHC) refers to an important application of monoclonal and polyclonal antibodies for tissue determination and distribution of antigens of a particular disease. It is majorly used to detect several infectious disorders such as dengue, hepatitis, and AIDS. Immunohistochemistry helps diagnose chronic medical conditions such as obesity, cancer, diabetes, heart disease, and stroke.

    According to the Joint United Nations Programme on HIV/AIDS (UNAIDS), 37.6 million people across the globe had HIV in 2020. 35.9 million were adults, and 1.7 million were children (<15 years old). An estimated 1.5 million individuals worldwide acquired HIV in 2020. According to the HIV and AIDS organization (AVERT), in 2018, 1.1 million US residents were infected with HIV, whereas APAC registered 5.2 million HIV-infected population. According to the European CDC, ~2 million people in Europe were infected with HIV in 2018.

    Diabetes is prevailing at a high rate in the geriatric population worldwide. The prevalence of diabetes is more in overweight and obese people. As per data published by the Centers for Disease Control and Prevention (CDC) in 2017, ~30.3 million people, representing 94% of the population of the US, were diabetic. Among these, ~23.1 million people were diagnosed with diabetes, while ~7.2 million had not undergone a proper diagnostic procedure.

    The obesity rates have been increasing rapidly in developed as well as developing economies across the globe. Factors such as unhealthy lifestyles and sedentary life are significant factors for the rise in the number of obese individuals. As per the data published by National Center for Health Statistics (NCHS), the prevalence of obesity is expected to be around 39.8%, affecting about 93.3 million US adults between the years 2015 to 2016. The incidence of obesity was significantly high among middle-aged adults (42.7%) compared to younger adults (35.7%). The increase in the number of obese people in the US has also led to rising healthcare expenditure.

    Cardiovascular diseases (CVDs) include cerebrovascular disease, rheumatic heart disease, coronary heart disease, and other conditions. It is the most significant cause of morbidity and mortality worldwide. According to the European Cardiovascular Disease Statistics 2017, every year, cardiovascular diseases cause 3.9 million deaths and more than 1.8 million deaths in the European Union (EU). CVDs account for 45.0% of all deaths in Europe and 37.0% of deaths in the EU. Furthermore, as per the American Heart Association (AHA) 2019 statistics, 121.5 million adults in the US—which is around half of the US adult population—suffer from cardiovascular diseases.

    Furthermore, there has been a rise in cancer incidence and mortality rates worldwide, making cancer the leading cause of death. According to the World Health Organization (WHO), in 2018, cancer was the cause of approximately 9.6 million deaths worldwide.

    Moreover, according to the National Cancer Institute, in 2018, approximately 1,735,350 new cancer cases were diagnosed in the US. Similarly, in China, as per the data revealed by WHO, ~4.3 million new cancer cases were detected, and 2.9 million cancer deaths were recorded in 2018. Such an increase in the incidence of chronic and infectious diseases is expected to create a demand for immunoassay tests worldwide.

    Increasing Geriatric Population Contribute Significantly to Immunohistochemistry Market Growth

    The increasing prevalence of chronic diseases can be majorly attributed to the growing elderly population. Aging is a complex process influenced by genetic variables, as well as environmental factors. Thus, people in the age group of 75 years and above, suffering from high blood pressure, are the common risk factor for cardiovascular diseases, including blood-associated cancer. Management of these disorders in older patients must often be weighed in a setting of decreased physiological reserves and concurrent illnesses.

    According to the United Nation's World Population Ageing 2017 report, in 2017, 962 million people across the world were aged 60 years or over. The number is expected to reach nearly 2.1 billion by 2050. In addition, according to the US Census Bureau, the number of Americans above the age of 65 and older is anticipated to grow more than double from 46 million in 2016 to above 98 million by 2060, and the 65-and-older age group's share in the world's population will increase to around 24% from 15%.

    In 2017, Europe had the most significant percentage of the population of age group 60 or above (25%). According to the European Union (EU), the share of those aged 80 years or above is predicted to almost triple between 2011 and 2060. Rapid aging is occurring in other parts of the world as well. By 2050, all regions of the world, except Africa, will have nearly a quarter or more of their populations aging 60 and above. The number of older persons in the world is anticipated to be US$ 1.4 billion in 2030 and US$ 2.1 billion in 2050 and will rise above US$ 3.1 billion in 2100.

    According to the National Council on Aging, approximately 80% of adults suffer from at least one chronic disease, whereas 77% of aged people suffer from two. These chronic diseases majorly comprise cancer, heart disease, diabetes, and stroke. Immunohistochemistry techniques help in the quantification and diagnosis of these diseases accurately and reliably. The rising geriatric population in the world is likely to boost the growth of the immunohistochemistry market during the forecast period.

    Product Insights

    Based on product, the global immunohistochemistry market is segmented into antibodies, equipment, reagents, and kits. In 2020, the antibodies segment held the largest share of the market. However, the reagents segment is expected to register the highest CAGR in the market during 2021–2028. In immunohistochemistry, antibodies provide extremely high identification precision at the protein level, with better sensitivity and localization at the cellular or even subcellular scale. In the immunohistochemistry market, companies such as Thermo Fisher Scientific, Inc. and Bio-Rad Laboratories, Inc. provide antibodies for better analysis of the assays, which is expected to drive the market during the forecast period.

    Application Insights

    Based on application, the immunohistochemistry market is segmented into diagnostics and drug testing. The diagnostics segment held a larger market share in 2021. Moreover, the same segment is expected to hold a significant market share in the immunohistochemistry market due to the increasing use of IHC to diagnose various chronic diseases such as cancer, autoimmune diseases, infectious diseases, and nephrological diseases. The increase in the detection and diagnosis of various medical conditions worldwide is expected to drive the segment's growth.

    End User Insights

    Based on end user, the immunohistochemistry market is segmented into hospital & diagnostic laboratories, research institutes, and others. The hospital & diagnostic laboratories segment held the largest market share in 2021, and it is expected to continue dominating the market by 2028. The hospital & diagnostic laboratories segment is expected to hold a significant market share in the immunohistochemistry market due to the segment is also expected to grow at the fastest rate during the coming years owing to the hospitals are among the essential parts of the healthcare system of any country. Technological advancements aid hospitals in diagnosing and treating various disorders such as cardio, neuro, HIV, Hepatitis, oncology, and others.

    Immunohistochemistry Market, by Product – 2021 and 2028
    Immunohistochemistry Market, by Product – 2021 and 2028

    Get more information on this report :



    Strategic Insights

    Product launches and mergers and acquisitions are highly adopted strategies by the players operating in the global immunohistochemistry market. A few of the recent key product developments are listed below:

    In April 2020, Bio-Rad launched a blood-based immunoassay kit to detect COVID-19. It is a blood-based immunoassay kit to identify antibodies to the SARS-CoV-2, the virus that causes COVID-19.

    In September 2020, Thermo Fisher and Humanigen agreed to scale up the manufacturing of monoclonal antibodies for COVID-19. This business deal is expected to help scale up the manufacturing of California biotech's lenlizumab, a clinical-stage candidate for cytokine storm that the company was testing in severe COVID-19 patients for a possible emergency use approval following this year.

    Coronavirus immunohistochemistry antibodies are immunological methods used to identify members of the Coronaviridae family of RNA viruses that infect birds and mammals. Antibodies against antigens expressed by several coronavirus strains, including SARS-CoV-2, SARS-CoV, MERS, and other non-human pathogens like feline coronavirus. Common coronavirus antibody targets include nucleocapsid (N) and spike glycoprotein (S). These antibodies are intended for immunohistochemical applications. Immunohistochemistry analysis shows the detection of differential expression levels of SARS-CoV-2 Coronavirus Nucleocapsid and demonstrates antibody specificity. Several market players are launching immunoassay kits in the market. For instance, in April 2020, Bio-Rad launched a blood-based immunoassay kit to detect COVID-19. It is a blood-based immunoassay kit to identify antibodies to the SARS-CoV-2, the virus that causes Covid-19. Hence, the rising demand for immunoassay kits to detect COVID-19 is positively impacting the immunohistochemistry market growth.

    Immunohistochemistry – Market Segmentation

    The global immunohistochemistry market is segmented into product, application, end user, and geography. In terms of product, the market is segmented into antibodies, equipment, reagents, and kits. Based on application, the immunohistochemistry market is segmented into diagnostics and drug testing. Based on end user, the immunohistochemistry market is segmented into hospital & diagnostic laboratories, research institutes, and others. In terms of geography, the market is broadly segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South and Central America.

    Company Profiles

    • F. Hoffmann-LA Roche AG
    • Merck KGaA
    • PerkinElmer, Inc.
    • Thermo Fisher Scientific, Inc.
    • Abcam Plc
    • Agilent Technologies
    • Bio SB
    • Bio-Rad Laboratories
    • Cell Signaling Technology, Inc.
    • Danaher Corporation

    1. Introduction

    1.1 Scope of the Study

    1.2 The Insight Partners Research Report Guidance

    1.3 Market Segmentation

    1.3.1 Global Immunohistochemistry Market – By Product

    1.3.2 Global Immunohistochemistry Market – By Application

    1.3.3 Global Immunohistochemistry Market – By End User

    1.3.4 Global Immunohistochemistry Market – By Geography

    2. Global Immunohistochemistry Market – Key Takeaways

    3. Research Methodology

    3.1 Coverage

    3.2 Secondary Research

    3.3 Primary Research

    4. Immunohistochemistry Market – Market Landscape

    4.1 Overview

    4.2 PEST Analysis

    4.2.1 North America – PEST Analysis

    4.2.2 Europe– PEST Analysis

    4.2.3 Asia Pacific – PEST Analysis

    4.2.4 Middle East and Africa – PEST Analysis

    4.2.5 South and Central America (SCAM) – PEST Analysis

    4.3 Experts Opinion

    5. Immunohistochemistry Market – Key Market Dynamics

    5.1 Market Drivers

    5.1.1 Rising Incidences of Chronic and Infectious Diseases

    5.1.2 Increasing Geriatric Population

    5.1.3 Increasing R&D Investments by Biotechnology & Biopharmaceutical Companies

    5.2 Key Market Restraints

    5.2.1 Limitations Associated with Immunohistochemistry

    5.3 Key Market Opportunities

    5.3.1 Development Opportunities in Emerging Countries

    5.4 Future Trends

    5.4.1 Increasing Acceptance of Automation in Immunohistochemistry

    5.5 Impact Analysis

    6. Immunohistochemistry Market – Global Analysis

    6.1 Global Immunohistochemistry Market Revenue Forecast and Analysis

    6.2 Global Immunohistochemistry Market, By Geography - Forecast and Analysis

    6.3 Market Positioning of Key Players

    7. Global Immunohistochemistry Market Revenue and Forecasts To 2028– by Product

    7.1 Overview

    7.2 Global Immunohistochemistry Market, By Product 2021 & 2028 (%)

    7.3 Antibodies

    7.3.1 Overview

    7.3.2 Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)

    7.3.3 Primary Antibodies

    7.3.3.1 Overview

    7.3.3.2 Primary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)

    7.3.4 Secondary Antibodies

    7.3.4.1 Overview

    7.3.4.2 Secondary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)

    7.4 Equipment Market

    7.4.1 Overview

    7.4.2 Equipment: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)

    7.4.3 Slide Staining Systems

    7.4.3.1 Overview

    7.4.3.2 Slide Staining Systems: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)

    7.4.4 Tissue Microarrays

    7.4.4.1 Overview

    7.4.4.2 Tissue Microarrays: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)

    7.4.5 Tissue Processing Systems

    7.4.5.1 Overview

    7.4.5.2 Tissue Processing Systems: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)

    7.4.6 Slide Scanners

    7.4.6.1 Overview

    7.4.6.2 Slide Scanners: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)

    7.4.7 Other Equipments

    7.4.7.1 Overview

    7.4.7.2 Other Equipments: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)

    7.5 Reagents Market

    7.5.1 Overview

    7.5.2 Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)

    7.5.3 Histological Stains

    7.5.3.1 Overview

    7.5.3.2 Histological Stains: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)

    7.5.4 Blocking Sera & Reagents Market

    7.5.4.1 Overview

    7.5.4.2 Blocking Sera & Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)

    7.5.5 Chromogenic Substrates Market

    7.5.5.1 Overview

    7.5.5.2 Chromogenic Substrates: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)

    7.5.6 Stabilizers

    7.5.6.1 Overview

    7.5.6.2 Global Stabilizers Market Revenue and Forecasts to 2028(US$ Mn)

    7.5.7 Proteolytic Enzymes

    7.5.7.1 Overview

    7.5.7.2 Proteolytic Enzymes: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)

    7.5.8 Organic Solvents

    7.5.8.1 Overview

    7.5.8.2 Organic Solvents: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)

    7.5.9 Fixation Reagents

    7.5.9.1 Overview

    7.5.9.2 Fixation Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)

    7.5.10 Diluents

    7.5.10.1 Overview

    7.5.10.2 Diluents: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)

    7.6 Kits Market

    7.6.1 Overview

    7.6.2 Kits: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)

    8. Immunohistochemistry Market Revenue and Forecasts To 2028 – Application

    8.1 Overview

    8.2 Global Immunohistochemistry Market Share by Application 2021 & 2028 (%)

    8.3 Diagnostics

    8.3.1 Overview

    8.3.2 Diagnostics Market Revenue and Forecast to 2028 (US$ Mn)

    8.3.3 Cancer

    8.3.3.1 Overview

    8.3.3.2 Cancer Market Revenue and Forecast to 2028 (US$ Mn)

    8.3.4 Infectious Diseases

    8.3.4.1 Overview

    8.3.4.2 Infectious Diseases Market Revenue and Forecast to 2028 (US$ Mn)

    8.3.5 Autoimmune Diseases

    8.3.5.1 Overview

    8.3.5.2 Autoimmune Diseases Market Revenue and Forecast to 2028 (US$ Mn)

    8.3.6 Diabetes Mellitus Market

    8.3.6.1 Overview

    8.3.6.2 Diabetes Mellitus Market Revenue and Forecast to 2028 (US$ Mn)

    8.3.7 Nephrological Diseases

    8.3.7.1 Overview

    8.3.7.2 Nephrological Diseases Market Revenue and Forecast to 2028 (US$ Mn)

    8.3.8 Others

    8.3.8.1 Overview

    8.3.8.2 Others Market Revenue and Forecast to 2028 (US$ Mn)

    8.4 Drug Testing

    8.4.1 Overview

    8.4.2 Drug Testing Market Revenue and Forecast to 2028 (US$ Mn)

    9. Global Immunohistochemistry Market Revenue and Forecasts To 2028– by End User

    9.1 Overview

    9.2 Global Immunohistochemistry Market, By End User 2021 & 2028 (%)

    9.3 Hospital & Diagnostic Laboratories

    9.3.1 Overview

    9.3.2 Global Hospital & Diagnostic Laboratories: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)

    9.4 Research Institutes Market

    9.4.1 Overview

    9.4.2 Research Institutes: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)

    9.5 Others

    9.5.1 Overview

    9.5.2 Others: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)

    10. Immunohistochemistry Market Revenue and Forecasts to 2028 – Geographical Analysis

    10.1 North America Immunohistochemistry Market Revenue and Forecasts To 2028

    10.1.1 North America Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    10.1.2 North America Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

    10.1.2.1 North America Diagnostics Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

    10.1.2.2 North America Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

    10.1.2.3 North America Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

    10.1.3 North America Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)

    10.1.3.1 North America Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)

    10.1.4 North America Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

    10.1.5 North America Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)

    10.1.5.1 US Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    10.1.5.1.1 US Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    10.1.5.1.2 US Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

    10.1.5.1.2.1 US Diagnostics Market Revenue and Forecasts To 2028, By Equipments (US$ Mn)

    10.1.5.1.2.2 US Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

    10.1.5.1.2.3 US Antibodies Market Revenue and Forecasts To 2028, By Reagents (US$ Mn)

    10.1.5.1.3 US Equipment Market Revenue and Forecasts To 2028, By Application (US$ Mn)

    10.1.5.1.3.1 US Reagents Market Revenue and Forecasts To 2028, By Diagnostics (US$ Mn)

    10.1.5.1.4 US Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

    10.1.5.2 Canada Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    10.1.5.2.1 Canada Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    10.1.5.2.2 Canada Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

    10.1.5.2.2.1 Canada Diagnostics Market Revenue and Forecasts To 2028, By Equipments (US$ Mn)

    10.1.5.2.2.2 Canada Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

    10.1.5.2.2.3 Canada Antibodies Market Revenue and Forecasts To 2028, By Reagents (US$ Mn)

    10.1.5.2.3 Canada Equipment Market Revenue and Forecasts To 2028, By Application (US$ Mn)

    10.1.5.2.3.1 Canada Reagents Market Revenue and Forecasts To 2028, By Diagnostics (US$ Mn)

    10.1.5.2.4 Canada Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

    10.1.5.3 Mexico Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    10.1.5.3.1 Mexico Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    10.1.5.3.2 Mexico Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

    10.1.5.3.2.1 Mexico Diagnostics Market Revenue and Forecasts To 2028, By Equipments (US$ Mn)

    10.1.5.3.2.2 Mexico Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

    10.1.5.3.2.3 Mexico Antibodies Market Revenue and Forecasts To 2028, By Type (US$ Mn)

    10.1.5.3.3 Mexico Equipment Market Revenue and Forecasts To 2028, By Application (US$ Mn)

    10.1.5.3.3.1 Mexico Reagents Market Revenue and Forecasts To 2028, By Diagnostics (US$ Mn)

    10.1.5.3.4 Mexico Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

    10.2 Europe: Immunohistochemistry Market Revenue and Forecasts to 2028

    10.2.1 Europe: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    10.2.2 Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

    10.2.2.1 Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

    10.2.2.2 Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

    10.2.2.3 Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

    10.2.3 Europe Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)

    10.2.3.1 Europe Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

    10.2.4 Europe Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)

    10.2.5 Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)

    10.2.5.1 UK Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    10.2.5.1.1 UK Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    10.2.5.1.2 UK Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

    10.2.5.1.2.1 UK Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

    10.2.5.1.2.2 UK Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

    10.2.5.1.2.3 UK Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

    10.2.5.1.3 UK Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)

    10.2.5.1.3.1 UK Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

    10.2.5.1.4 UK Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)

    10.2.5.2 Germany Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    10.2.5.2.1 Germany Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    10.2.5.2.2 Germany Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

    10.2.5.2.2.1 Germany Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

    10.2.5.2.2.2 Germany Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

    10.2.5.2.2.3 Germany Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

    10.2.5.2.3 Germany Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)

    10.2.5.2.3.1 Germany Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

    10.2.5.2.4 Germany Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)

    10.2.5.3 France Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    10.2.5.3.1 France Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    10.2.5.3.2 France Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

    10.2.5.3.2.1 France Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

    10.2.5.3.2.2 France Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

    10.2.5.3.2.3 France Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

    10.2.5.3.3 France Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)

    10.2.5.3.3.1 France Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

    10.2.5.3.4 France Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)

    10.2.5.4 Italy Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    10.2.5.4.1 Italy Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    10.2.5.4.2 Italy Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

    10.2.5.4.2.1 Italy Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

    10.2.5.4.2.2 Italy Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

    10.2.5.4.2.3 Italy Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

    10.2.5.4.3 Italy Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)

    10.2.5.4.3.1 Italy Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

    10.2.5.4.4 Italy Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)

    10.2.5.5 Spain Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    10.2.5.5.1 Spain Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    10.2.5.5.2 Spain Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

    10.2.5.5.2.1 Spain Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

    10.2.5.5.2.2 Spain Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

    10.2.5.5.2.3 Spain Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

    10.2.5.5.3 Spain Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)

    10.2.5.5.3.1 Spain Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

    10.2.5.5.4 Spain Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)

    10.2.5.6 Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    10.2.5.6.1 Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    10.2.5.6.2 Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

    10.2.5.6.2.1 Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

    10.2.5.6.2.2 Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

    10.2.5.6.2.3 Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

    10.2.5.6.3 Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)

    10.2.5.6.3.1 Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

    10.2.5.6.4 Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)

    10.3 Asia Pacific Immunohistochemistry Market Revenue and Forecasts To 2028

    10.3.1 Overview

    10.3.2 Asia Pacific Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)

    10.3.3 Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

    10.3.3.1 Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

    10.3.3.2 Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

    10.3.3.3 Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

    10.3.4 Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)

    10.3.4.1 Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

    10.3.5 Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

    10.3.6 Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)

    10.3.6.1 Japan: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)

    10.3.6.1.1 Japan: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)

    10.3.6.1.2 Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

    10.3.6.1.2.1 Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

    10.3.6.1.2.2 Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

    10.3.6.1.2.3 Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

    10.3.6.1.3 Japan Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)

    10.3.6.1.3.1 Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

    10.3.6.1.4 Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

    10.3.6.2 China: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)

    10.3.6.2.1 China: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)

    10.3.6.2.2 China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

    10.3.6.2.2.1 China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

    10.3.6.2.2.2 China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

    10.3.6.2.2.3 China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

    10.3.6.2.3 China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)

    10.3.6.2.3.1 China: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

    10.3.6.2.4 China: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

    10.3.6.3 India Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)

    10.3.6.3.1 India: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)

    10.3.6.3.2 India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

    10.3.6.3.2.1 India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

    10.3.6.3.2.2 India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

    10.3.6.3.2.3 India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

    10.3.6.3.3 India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)

    10.3.6.3.3.1 India: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

    10.3.6.3.4 India: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

    10.3.6.4 South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)

    10.3.6.4.1 South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)

    10.3.6.4.3 South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

    10.3.6.4.3.1 South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

    10.3.6.4.3.2 South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

    10.3.6.4.3.3 South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

    10.3.6.4.4 South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

    10.3.6.5 Australia: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)

    10.3.6.5.1 Australia: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)

    10.3.6.5.2 Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

    10.3.6.5.2.1 Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

    10.3.6.5.2.2 Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

    10.3.6.5.2.3 Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

    10.3.6.5.3 Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)

    10.3.6.5.3.1 Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

    10.3.6.5.4 Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

    10.3.6.6 Rest of Asia Pacific: Immunohistochemistry Market – Revenue and Forecast to 2028 (USD Million)

    10.3.6.6.1 Rest of Asia Pacific: Immunohistochemistry Market – Revenue and Forecast to 2028 (USD Million)

    10.3.6.6.2 Rest of Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

    10.3.6.6.2.1 Rest of Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

    10.3.6.6.2.2 Rest of Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

    10.3.6.6.2.3 Rest of Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

    10.3.6.6.3 Rest of Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)

    10.3.6.6.3.1 Rest of Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

    10.3.6.6.4 Rest of Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

    10.4 Middle East & Africa Immunohistochemistry Market Revenue and Forecasts To 2028

    10.4.1 Middle East & Africa Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    10.4.2 Middle East & Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

    10.4.2.1 Middle East & Africa Diagnostics Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

    10.4.2.2 Middle East & Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

    10.4.2.3 Middle East & Africa Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

    10.4.3 Middle East & Africa Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)

    10.4.3.1 Middle East & Africa Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)

    10.4.4 Middle East & Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

    10.4.5 Middle East & Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)

    10.4.5.1 UAE Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    10.4.5.1.1 UAE Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    10.4.5.1.2 UAE Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

    10.4.5.1.2.1 UAE Diagnostics Market Revenue and Forecasts To 2028, By Equipments (US$ Mn)

    10.4.5.1.2.2 UAE Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

    10.4.5.1.2.3 UAE Antibodies Market Revenue and Forecasts To 2028, By Reagents (US$ Mn)

    10.4.5.1.3 UAE Equipment Market Revenue and Forecasts To 2028, By Application (US$ Mn)

    10.4.5.1.3.1 UAE Reagents Market Revenue and Forecasts To 2028, By Diagnostics (US$ Mn)

    10.4.5.1.4 UAE Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

    10.4.5.2 Saudi Arabia Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    10.4.5.2.1 Saudi Arabia Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    10.4.5.2.2 Saudi Arabia Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

    10.4.5.2.2.1 Saudi Arabia Diagnostics Market Revenue and Forecasts To 2028, By Equipments (US$ Mn)

    10.4.5.2.2.2 Saudi Arabia Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

    10.4.5.2.2.3 Saudi Arabia Antibodies Market Revenue and Forecasts To 2028, By Reagents (US$ Mn)

    10.4.5.2.3 Saudi Arabia Equipment Market Revenue and Forecasts To 2028, By Application (US$ Mn)

    10.4.5.2.3.1 Saudi Arabia Reagents Market Revenue and Forecasts To 2028, By Diagnostics (US$ Mn)

    10.4.5.2.4 Saudi Arabia Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

    10.4.5.3 South Africa Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    10.4.5.3.1 South Africa Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    10.4.5.3.2 South Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

    10.4.5.3.2.1 South Africa Diagnostics Market Revenue and Forecasts To 2028, By Equipments (US$ Mn)

    10.4.5.3.2.2 South Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

    10.4.5.3.2.3 South Africa Antibodies Market Revenue and Forecasts To 2028, By Reagents (US$ Mn)

    10.4.5.3.3 South Africa Equipment Market Revenue and Forecasts To 2028, By Application (US$ Mn)

    10.4.5.3.3.1 South Africa Reagents Market Revenue and Forecasts To 2028, By Diagnostics (US$ Mn)

    10.4.5.3.4 South Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

    10.4.5.4 Rest of Middle East and Africa Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    10.4.5.4.1 Rest of Middle East and Africa Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    10.4.5.4.2 Rest of Middle East & Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

    10.4.5.4.2.1 Rest of Middle East & Africa Diagnostics Market Revenue and Forecasts To 2028, By Equipments (US$ Mn)

    10.4.5.4.2.2 Rest of Middle East & Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

    10.4.5.4.2.3 Rest of Middle East & Africa Antibodies Market Revenue and Forecasts To 2028, By Reagents (US$ Mn)

    10.4.5.4.3 Rest of Middle East & Africa Equipment Market Revenue and Forecasts To 2028, By Application (US$ Mn)

    10.4.5.4.3.1 Rest of Middle East & Africa Reagents Market Revenue and Forecasts To 2028, By Diagnostics (US$ Mn)

    10.4.5.4.4 Rest of Middle East & Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

    10.5 South And Central America Immunohistochemistry Market Revenue and Forecasts To 2028

    10.5.1 South and Central America Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    10.5.2 South and Central America Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

    10.5.2.1 South and Central America Diagnostics Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

    10.5.2.2 South and Central America Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

    10.5.2.3 South and Central America Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

    10.5.3 South and Central America Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)

    10.5.3.1 South and Central America Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)

    10.5.4 South and Central America Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

    10.5.5 South and Central America Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)

    10.5.5.1 Argentina Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    10.5.5.1.1 Argentina Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    10.5.5.1.2 Argentina Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

    10.5.5.1.2.1 Argentina Diagnostics Market Revenue and Forecasts To 2028, By Equipments (US$ Mn)

    10.5.5.1.2.2 Argentina Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

    10.5.5.1.2.3 Argentina Antibodies Market Revenue and Forecasts To 2028, By Reagents (US$ Mn)

    10.5.5.1.3 Argentina Equipment Market Revenue and Forecasts To 2028, By Application (US$ Mn)

    10.5.5.1.3.1 Argentina Reagents Market Revenue and Forecasts To 2028, By Diagnostics (US$ Mn)

    10.5.5.1.4 Argentina Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

    10.5.5.2 Brazil Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    10.5.5.2.1 Brazil Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    10.5.5.2.2 Brazil Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

    10.5.5.2.2.1 Brazil Diagnostics Market Revenue and Forecasts To 2028, By Equipments (US$ Mn)

    10.5.5.2.2.2 Brazil Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

    10.5.5.2.2.3 Brazil Antibodies Market Revenue and Forecasts To 2028, By Reagents (US$ Mn)

    10.5.5.2.3 Brazil Equipment Market Revenue and Forecasts To 2028, By Application (US$ Mn)

    10.5.5.2.3.1 Brazil Reagents Market Revenue and Forecasts To 2028, By Diagnostics (US$ Mn)

    10.5.5.2.4 Brazil Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

    10.5.5.3 Rest of South and Central America: Immunohistochemistry Market– Revenue and Forecast to 2028 (USD Mn)

    10.5.5.3.1 Rest of South and Central America: Immunohistochemistry Market– Revenue and Forecast to 2028 (USD Mn)

    10.5.5.3.2 Rest of South & Central America Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

    10.5.5.3.2.1 Rest of South & Central America Diagnostics Market Revenue and Forecasts To 2028, By Equipments (US$ Mn)

    10.5.5.3.2.2 Rest of South & Central America Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

    10.5.5.3.2.3 Rest of South & Central America Antibodies Market Revenue and Forecasts To 2028, By Reagents (US$ Mn)

    10.5.5.3.3 Rest of South & Central America Equipment Market Revenue and Forecasts To 2028, By Application (US$ Mn)

    10.5.5.3.3.1 Rest of South & Central America Reagents Market Revenue and Forecasts To 2028, By Diagnostics (US$ Mn)

    10.5.5.3.4 Rest of South & Central America Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

    11. Impact Of COVID-19 Pandemic on Immunohistochemistry Market

    11.1 North America: Impact Assessment of COVID-19 Pandemic

    11.2 Europe: Impact Assessment of COVID-19 Pandemic

    11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic

    11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic

    11.5 South and Central America: Impact Assessment of COVID-19 Pandemic

    12. Immunohistochemistry Market–Industry Landscape

    12.1 Overview

    12.2 Growth Strategies Done by the Companies in the Market (%)

    12.3 Organic Developments

    12.3.1 Overview

    12.4 Inorganic developments

    12.4.1 Overview

    13. Company Profiles

    13.1 Cell Signaling Technology, Inc.

    13.1.1 Key Facts

    13.1.2 Business Description

    13.1.3 Products and Services

    13.1.4 Financial Overview

    13.1.5 SWOT Analysis

    13.1.6 Key Developments

    13.2 F. HOFFMANN-LA ROCHE LTD.

    13.2.1 Key Facts

    13.2.2 Business Description

    13.2.3 Products and Services

    13.2.4 Financial Overview

    13.2.5 SWOT Analysis

    13.2.6 Key Developments

    13.3 MERCK KGaA

    13.3.1 Key Facts

    13.3.2 Business Description

    13.3.3 Products and Services

    13.3.4 Financial Overview

    13.3.5 SWOT Analysis

    13.3.6 Key Developments

    13.4 PerkinElmer Inc.

    13.4.1 Key Facts

    13.4.2 Business Description

    13.4.3 Products and Services

    13.4.4 Financial Overview

    13.4.5 SWOT Analysis

    13.4.6 Key Developments

    13.5 THERMO FISHER SCIENTIFIC INC.

    13.5.1 Key Facts

    13.5.2 Business Description

    13.5.3 Products and Services

    13.5.4 Financial Overview

    13.5.5 SWOT Analysis

    13.5.6 Key Developments

    13.6 Abcam plc

    13.6.1 Key Facts

    13.6.2 Business Description

    13.6.3 Products and Services

    13.6.4 Financial Overview

    13.6.5 SWOT Analysis

    13.6.6 Key Developments

    13.7 Agilent Technologies, Inc.

    13.7.1 Key Facts

    13.7.2 Business Description

    13.7.3 Products and Services

    13.7.4 Financial Overview

    13.7.5 SWOT Analysis

    13.7.6 Key Developments

    13.8 BIO-RAD LABORATORIES INC.

    13.8.1 Key Facts

    13.8.2 Business Description

    13.8.3 Products and Services

    13.8.4 Financial Overview

    13.8.5 SWOT Analysis

    13.8.6 Key Developments

    13.9 Danaher

    13.9.1 Key Facts

    13.9.2 Business Description

    13.9.3 Products and Services

    13.9.4 Financial Overview

    13.9.5 SWOT Analysis

    13.9.6 Key Developments

    13.10 Bio SB

    13.10.1 Key Facts

    13.10.2 Business Description

    13.10.3 Products and Services

    13.10.4 Financial Overview

    13.10.5 SWOT Analysis

    13.10.6 Key Developments

    14. Appendix

    14.1 About The Insight Partners

    14.2 Glossary of Terms

    LIST OF TABLES

    Table 1. R&D Investments by Major Biopharmaceutical Companies

    Table 2. North America Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

    Table 3. North America Diagnostics Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

    Table 4. North America Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

    Table 5. North America Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

    Table 6. North America Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)

    Table 7. North America Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)

    Table 8. North America Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

    Table 9. US Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

    Table 10. US Diagnostics Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

    Table 11. US Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

    Table 12. US Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

    Table 13. US Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)

    Table 14. US Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)

    Table 15. US Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

    Table 16. Canada Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

    Table 17. Canada Diagnostics Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

    Table 18. Canada Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

    Table 19. Canada Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

    Table 20. Canada Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)

    Table 21. Canada Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)

    Table 22. Canada Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

    Table 23. Mexico Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

    Table 24. Mexico Diagnostics Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

    Table 25. Mexico Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

    Table 26. Mexico Antibodies Market Revenue and Forecasts to 2028, By Type (US$ Mn)

    Table 27. Mexico Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)

    Table 28. Mexico Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)...................................................................

    Table 29. Mexico Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

    Table 30. Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn).

    Table 31. Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn).

    Table 32. Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn).

    Table 33. Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn).

    Table 34. Europe Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)

    Table 35. Europe Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

    Table 36. Europe Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)

    Table 37. UK Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

    Table 38. UK Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

    Table 39. UK Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

    Table 40. UK Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

    Table 41. UK Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)

    Table 42. UK Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

    Table 43. UK Immunohistochemistry Market Revenue and Forecasts to 2028, by End User US$ Mn)

    Table 44. Germany Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

    Table 45. Germany Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

    Table 46. Germany Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

    Table 47. Germany Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

    Table 48. Germany Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)

    Table 49. Germany Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

    Table 50. Germany Immunohistochemistry Market Revenue and Forecasts to 2028, by End User US$ Mn)

    Table 51. France Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

    Table 52. France Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

    Table 53. France Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

    Table 54. France Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

    Table 55. France Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)

    Table 56. France Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

    Table 57. France Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)

    Table 58. Italy Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

    Table 59. Italy Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

    Table 60. Italy Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

    Table 61. Italy Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

    Table 62. Italy Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)

    Table 63. Italy Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

    Table 64. Italy Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)

    Table 65. Spain Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

    Table 66. Spain Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

    Table 67. Spain Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

    Table 68. Spain Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

    Table 69. Spain Immunohistochemistry Market Revenue and Forecast to 2028, by Application (USD Million)

    Table 70. Spain Immunohistochemistry Market Revenue and Forecast to 2028, by Diagnostics (USD Million)

    Table 71. Spain Immunohistochemistry Market Revenue and Forecast to 2028, by End User (USD Million)

    Table 72. Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

    Table 73. Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

    Table 74. Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

    Table 75. Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

    Table 76. Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)

    Table 77. Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

    Table 78. Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)

    Table 79. Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

    Table 80. Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

    Table 81. Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

    Table 82. Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

    Table 83. Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)

    Table 84. Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

    Table 85. Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

    Table 86. Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

    Table 87. Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

    Table 88. Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

    Table 89. Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

    Table 90. Japan Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)

    Table 91. Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

    Table 92. Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

    Table 93. China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

    Table 94. China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

    Table 95. China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

    Table 96. China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

    Table 97. China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)

    Table 98. China: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

    Table 99. China: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

    Table 100. India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

    Table 101. India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

    Table 102. India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

    Table 103. India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

    Table 104. India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)

    Table 105. India: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

    Table 106. India: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

    Table 107. South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

    Table 108. South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

    Table 109. South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

    Table 110. South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

    Table 111. South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

    Table 112. Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

    Table 113. Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

    Table 114. Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

    Table 115. Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

    Table 116. Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)

    Table 117. Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

    Table 118. Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

    Table 119. Rest of Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

    Table 120. Rest of Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

    Table 121. Rest of Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

    Table 122. Rest of Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

    Table 123. Rest of Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)

    Table 124. Rest of Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

    Table 125. Rest of Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

    Table 126. Middle East & Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

    Table 127. Middle East & Africa Diagnostics Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

    Table 128. Middle East & Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

    Table 129. Middle East & Africa Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

    Table 130. Middle East & Africa Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)

    Table 131. Middle East & Africa Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)

    Table 132. Middle East & Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

    Table 133. UAE Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

    Table 134. UAE Diagnostics Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

    Table 135. UAE Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

    Table 136. UAE Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

    Table 137. UAE Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)

    Table 138. UAE Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)

    Table 139. UAE Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

    Table 140. Saudi Arabia Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

    Table 141. Saudi Arabia Diagnostics Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

    Table 142. Saudi Arabia Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

    Table 143. Saudi Arabia Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

    Table 144. Saudi Arabia Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)

    Table 145. Saudi Arabia Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)

    Table 146. Saudi Arabia Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

    Table 147. South Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

    Table 148. South Africa Diagnostics Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

    Table 149. South Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

    Table 150. South Africa Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

    Table 151. South Africa Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)

    Table 152. South Africa Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)

    Table 153. South Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

    Table 154. Rest of Middle East & Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

    Table 155. Rest of Middle East & Africa Diagnostics Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

    Table 156. Rest of Middle East & Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

    Table 157. Rest of Middle East & Africa Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

    Table 158. Rest of Middle East & Africa Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)

    Table 159. Rest of Middle East & Africa Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)

    Table 160. Rest of Middle East & Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

    Table 161. South and Central America Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

    Table 162. South and Central America Diagnostics Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

    Table 163. South and Central America Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

    Table 164. South and Central America Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

    Table 165. South and Central America Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)

    Table 166. South and Central America Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)

    Table 167. South and Central America Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

    Table 168. Argentina Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

    Table 169. Argentina Diagnostics Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

    Table 170. Argentina Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

    Table 171. Argentina Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

    Table 172. Argentina Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)

    Table 173. Argentina Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)

    Table 174. Argentina Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

    Table 175. Brazil Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

    Table 176. Brazil Diagnostics Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

    Table 177. Brazil Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

    Table 178. Brazil Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

    Table 179. Brazil Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)....................................................................

    Table 180. Brazil Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)

    Table 181. Brazil Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

    Table 182. Rest of South & Central America Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

    Table 183. Rest of South & Central America Diagnostics Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

    Table 184. Rest of South & Central America Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

    Table 185. Rest of South & Central America Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

    Table 186. Rest of South & Central America Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)

    Table 187. Rest of South & Central America Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)

    Table 188. Rest of South & Central America Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

    Table 189. Organic Developments Done By Companies

    Table 190. Inorganic developments done by Companies

    Table 191. Glossary of Terms, Immunohistochemistry Market

    LIST OF FIGURES

    Figure 1. Immunohistochemistry Market Segmentation

    Figure 2. Immunohistochemistry Market Segmentation, By Region

    Figure 3. Global Immunohistochemistry Market Overview

    Figure 4. Antibodies Segment Held the Largest Share of the Product Segment in Immunohistochemistry Market

    Figure 5. Asia Pacific to Show Significant Growth During Forecast Period

    Figure 6. Immunohistochemistry Market, by Geography (US$ Million)

    Figure 7. Global Immunohistochemistry Market – Leading Country Markets (US$ Million)

    Figure 8. Global Immunohistochemistry Market, Industry Landscape

    Figure 9. North America PEST Analysis

    Figure 10. Europe and PEST Analysis

    Figure 11. Asia Pacific PEST Analysis

    Figure 12. Middle East and Africa PEST Analysis

    Figure 13. South and Central America (SCAM) PEST Analysis

    Figure 14. Impact Analysis of Drivers and Restraints Pertaining to Immunohistochemistry Market

    Figure 15. Global Immunohistochemistry Market – Revenue Forecast and Analysis – 2020- 2028

    Figure 16. Global Immunohistochemistry Market – By Geography Forecast and Analysis – 2021- 2028

    Figure 17. Market Positioning of Key Players in Global Immunohistochemistry Market

    Figure 18. Global Immunohistochemistry Market, by Product 2021 & 2028 (%)

    Figure 19. Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)

    Figure 20. Primary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)

    Figure 21. Secondary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)

    Figure 22. Equipment: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)

    Figure 23. Slide Staining Systems: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)

    Figure 24. Tissue Microarrays: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)

    Figure 25. Tissue Processing Systems: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)

    Figure 26. Slide Scanners: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)

    Figure 27. Other Equipments: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)

    Figure 28. Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn).........................................................................

    Figure 29. Histological Stains: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)

    Figure 30. Blocking Sera & Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)

    Figure 31. Global Chromogenic Substrates: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)

    Figure 32. Stabilizer: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)

    Figure 33. Proteolytic Enzymes: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)

    Figure 34. Organic Solvents: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)

    Figure 35. Fixation Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)

    Figure 36. Diluents: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)

    Figure 37. Kits: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)

    Figure 38. Global Immunohistochemistry Market Share by Application 2021 & 2028 (%)

    Figure 39. Diagnostics Market Revenue and Forecasts To 2028 (US$ Mn)

    Figure 40. Cancer Market Revenue and Forecasts To 2028 (US$ Mn)

    Figure 41. Infectious Diseases Market Revenue and Forecasts To 2028 (US$ Mn)

    Figure 42. Autoimmune Diseases Market Revenue and Forecasts To 2028 (US$ Mn)

    Figure 43. Diabetes mellitus Market Revenue and Forecasts To 2028 (US$ Mn)

    Figure 44. Nephrological Diseases Market Revenue and Forecasts To 2028 (US$ Mn)

    Figure 45. Others Market Revenue and Forecasts To 2028 (US$ Mn)

    Figure 46. Drug Testing Market Revenue and Forecasts To 2028 (US$ Mn)

    Figure 47. Global Immunohistochemistry Market, by End User 2021 & 2028 (%)

    Figure 48. Hospital & Diagnostic Laboratories: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)

    Figure 49. Research Institutes: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)

    Figure 50. Others: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)

    Figure 51. North America Immunohistochemistry Market Revenue Overview, by Country (2021) (US$ Mn)

    Figure 52. North America Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    Figure 53. North America Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)

    Figure 54. US Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    Figure 55. Canada Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    Figure 56. Mexico Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    Figure 57. Europe: Immunohistochemistry Market Revenue Overview, by Country, 2021 (US$ MN)

    Figure 58. Europe Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    Figure 59. Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)

    Figure 60. UK Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    Figure 61. Germany Immunohistochemistry Products Market Revenue and Forecasts to 2028 (US$ Mn)

    Figure 62. France Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    Figure 63. Italy Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    Figure 64. Spain Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    Figure 65. Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    Figure 66. Asia Pacific Immunohistochemistry Market Overview, by Country (2018)

    Figure 67. Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)

    Figure 68. Asia Pacific: Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)

    Figure 69. Japan: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)

    Figure 70. China: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)

    Figure 71. India: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)

    Figure 72. South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn)

    Figure 73. Australia: Immunohistochemistry Market Revenue and Forecasts to 2028(US$ Mn).........................................................................

    Figure 74. Rest of Asia Pacific: Immunohistochemistry Market – Revenue and Forecast to 2028 (USD Million)

    Figure 75. Middle East & Africa Immunohistochemistry Market Revenue Overview, by Country, 2021 (US$ Mn)

    Figure 76. Middle East & Africa Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    Figure 77. Middle East & Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)

    Figure 78. UAE Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    Figure 79. Saudi Arabia Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    Figure 80. South Africa Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    Figure 81. Rest of Middle East and Africa Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    Figure 82. South and Central America Immunohistochemistry Market Revenue Overview, by Country, 2021 (US$ Mn)

    Figure 83. South and Central America Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    Figure 84. South and Central America Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)

    Figure 85. Argentina Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)........................................................................

    Figure 86. Brazil Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    Figure 87. Rest of South and Central America: Immunohistochemistry Market– Revenue and Forecast to 2028 (USD Mn)

    Figure 88. Impact of COVID-19 Pandemic in North American Country Markets

    Figure 89. Impact of COVID-19 Pandemic in European Country Markets

    Figure 90. Impact of COVID-19 Pandemic in Asia Pacific Country Markets

    Figure 91. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets

    Figure 92. Impact Of COVID-19 Pandemic in South and Central America Africa Country Markets...........................................................................

    Figure 93. Growth Strategies done by the companies in the Market (%)

    The List of Companies - Immunohistochemistry Market

    1. F. Hoffmann-LA Roche AG
    2. Merck KGaA
    3. PerkinElmer, Inc.
    4. Thermo Fisher Scientific, Inc.
    5. Abcam Plc
    6. Agilent Technologies
    7. Bio SB
    8. Bio-Rad Laboratories
    9. Cell Signaling Technology, Inc.
    10. Danaher Corporation
    • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the immunohistochemistry market.
    • Highlights key business priorities in order to assist companies to realign their business strategies.
    • The key findings and recommendations highlight crucial progressive industry trends in the global immunohistochemistry market, thereby allowing players across the value chain to develop effective long-term strategies.
    • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
    • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
    • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.   
    TIPRE00006184
    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Get the Latest COVID-19 Analysis on this market



    Frequently Asked Questions

    Immunohistochemistry is a tool used microscopy-based techniques to observe cellular components such as proteins or other macromolecules in a tissue sample. It is routinely used tool in health care and pathology. IHC is widely used in research application where molecules of interest are analyzed to study their roles in both healthy and diseased cells and tissues on the cellular, molecular, or tissue level. There are numerous IHC methods that can be used to localize antigens. Parameters like specimen types and assay sensitivity are majorly considered in IHC.
    Key factors driving the growth of the market are rising incidences of chronic and infectious diseases, increasing geriatric population, and increasing R&D investments by biotechnology & biopharmaceutical companies are among the key factors driving the market.
    Key players in the market are F. Hoffmann-LA Roche AG, Merck KGaA, PerkinElmer, Inc., Thermo Fisher Scientific, Inc., Abcam Plc, Agilent Technologies, Bio SB, Bio-Rad Laboratories, Cell Signaling Technology, Inc., and Danaher Corporation among others.
    Increasing acceptance of automation in immunohistochemistry is likely to act as trend the market growth in the comping years.
    Antibodies is the most influencing segment growing in the immunohistochemistry market.
    Development opportunities in emerging countries are likely to fuel the market growth in the comping years.
    Asia-Pacific is the lucrative for the immunohistochemistry market.

    Pricing
    • $3000
    • $4550 $3640
    • $6550 $5240
    • $8550 $6840

        GET FREE SAMPLE PDF

    Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

        Inquire for Discount   Speak to Analyst